Abstract | OBJECTIVE: To analyze the differences between ondansetron and palonosetron in healthcare resource use (i.e., inpatient/ outpatient encounters) among patients receiving intraperitoneal cisplatin. METHOD: RESULTS: CONCLUSION:
|
Authors | Yu-Chen Yeh, Anne McDonnell, Elissa Klinger, Bridget Fowler, Lina Matta, Daniel Voit, Prabashni Reddy |
Journal | Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
(J Oncol Pharm Pract)
Vol. 17
Issue 3
Pg. 179-85
(Sep 2011)
ISSN: 1477-092X [Electronic] England |
PMID | 20452991
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
- Antiemetics
- Antineoplastic Agents
- Isoquinolines
- Quinuclidines
- Serotonin Antagonists
- Ondansetron
- Palonosetron
- Cisplatin
|
Topics |
- Adult
- Aged
- Ambulatory Care
(statistics & numerical data)
- Antiemetics
(administration & dosage, adverse effects)
- Antineoplastic Agents
(administration & dosage, adverse effects)
- Boston
- Cisplatin
(administration & dosage, adverse effects)
- Drug Administration Schedule
- Drug Substitution
- Emergency Service, Hospital
(statistics & numerical data)
- Fallopian Tube Neoplasms
(drug therapy)
- Female
- Health Resources
(statistics & numerical data)
- Humans
- Isoquinolines
(administration & dosage, adverse effects)
- Length of Stay
- Middle Aged
- Nausea
(chemically induced, prevention & control)
- Ondansetron
(administration & dosage, adverse effects)
- Ovarian Neoplasms
(drug therapy)
- Palonosetron
- Patient Readmission
- Premedication
- Quinuclidines
(administration & dosage, adverse effects)
- Risk Assessment
- Risk Factors
- Serotonin Antagonists
(administration & dosage, adverse effects)
- Time Factors
- Treatment Outcome
- Vomiting
(chemically induced, prevention & control)
|